Statistical Modeling for Practical Pooled Testing During the COVID-19 Pandemic

Pooled testing offers an efficient solution to the unprecedented testing demands of the COVID-19 pandemic, although with potentially lower sensitivity and increased costs to implementation in some settings. Assessments of this trade-off typically assume pooled specimens are independent and identically distributed. Yet, in the context of COVID-19, these assumptions are often violated: testing done on networks (housemates, spouses, co-workers) captures correlated individuals, while infection risk varies substantially across time, place and individuals. Neglecting dependencies and heterogeneity may bias established optimality grids and induce a sub-optimal implementation of the procedure. As a lesson learned from this pandemic, this paper highlights the necessity of integrating field sampling information with statistical modeling to efficiently optimize pooled testing. Using real data, we show that (a) greater gains can be achieved at low logistical cost by exploiting natural correlations (non-independence) between samples —allowing improvements in sensitivity and efficiency of up to 30% and 90% respectively; and (b) these gains are robust despite substantial heterogeneity across pools (non-identical). Our modeling results complement and extend the observations of Barak et al. who report an empirical sensitivity well beyond expectations. Finally, we provide an interactive tool for selecting an optimal pool size using contextual information*.

[1]  Lawrence M. Wein,et al.  Pooled Testing for HIV Screening: Capturing the Dilution Effect , 2018, Oper. Res..

[2]  D. Havlir,et al.  Asymptomatic Transmission, the Achilles’ Heel of Current Strategies to Control Covid-19 , 2020, The New England journal of medicine.

[3]  Christopher S. McMahan,et al.  Informative Dorfman Screening , 2012, Biometrics.

[4]  Cheng-Shang Chang,et al.  Positively Correlated Samples Save Pooled Testing Costs , 2020, IEEE Transactions on Network Science and Engineering.

[5]  Joshua M Tebbs,et al.  Group Testing Regression Models with Fixed and Random Effects , 2009, Biometrics.

[6]  Peng Chen,et al.  Informative Retesting , 2010, Journal of the American Statistical Association.

[7]  Joshua M Tebbs,et al.  Pooled‐testing procedures for screening high volume clinical specimens in heterogeneous populations , 2012, Statistics in medicine.

[8]  Milind Tambe,et al.  Test sensitivity is secondary to frequency and turnaround time for COVID-19 surveillance , 2020, medRxiv : the preprint server for health sciences.

[9]  Christl A. Donnelly,et al.  The role of rapid diagnostics in managing Ebola epidemics , 2015, Nature.

[10]  R. Rannan-Eliya,et al.  Increased Intensity Of PCR Testing Reduced COVID-19 Transmission Within Countries During The First Pandemic Wave. , 2020, Health affairs.

[11]  Claire Donnat,et al.  Modeling the heterogeneity in COVID-19's reproductive number and its impact on predictive scenarios , 2020, Journal of Applied Statistics.

[12]  A. Green-Saxena,et al.  Correlation of Population SARS-CoV-2 Cycle Threshold Values to Local Disease Dynamics: Exploratory Observational Study , 2021, JMIR public health and surveillance.

[13]  Benjamin J Cowling,et al.  Clustering and superspreading potential of SARS-CoV-2 infections in Hong Kong , 2020, Nature Medicine.

[14]  COVID-19 Super-spreaders: Definitional Quandaries and Implications , 2020, Asian bioethics review.

[15]  T. Bärnighausen,et al.  Simulation of pooled-sample analysis strategies for COVID-19 mass testing , 2020, Bulletin of the World Health Organization.

[16]  B. Kessel,et al.  Prevalence of Asymptomatic SARS-CoV-2 Infection , 2021, Annals of Internal Medicine.

[17]  J. Zehnder,et al.  Performance of Nucleic Acid Amplification Tests for Detection of Severe Acute Respiratory Syndrome Coronavirus 2 in Prospectively Pooled Specimens , 2020, Emerging infectious diseases.

[18]  Kohji Yamamura,et al.  Estimation of the Proportion of Defective Units by Using Group Testing Under the Existence of a Threshold of Detection , 2007, Commun. Stat. Simul. Comput..

[19]  Lu Wang,et al.  Evaluating Transmission Heterogeneity and Super-Spreading Event of COVID-19 in a Metropolis of China , 2020, medRxiv.

[20]  A. Pollock,et al.  Asymptomatic transmission of covid-19 , 2020, BMJ.

[21]  Yuguo Chen,et al.  Familial cluster of COVID-19 infection from an asymptomatic , 2020, Critical Care.

[22]  J. Rewley,et al.  Specimen Pooling to Conserve Additional Testing Resources When Persons’ Infection Status Is Correlated , 2020, Epidemiology.

[23]  Daniel B Larremore,et al.  Rethinking Covid-19 Test Sensitivity - A Strategy for Containment. , 2020, The New England journal of medicine.

[24]  Marcello Pagano,et al.  On the informativeness and accuracy of pooled testing in estimating prevalence of a rare disease: Application to HIV screening , 1995 .

[25]  J L Gastwirth,et al.  The efficiency of pooling in the detection of rare mutations. , 2000, American journal of human genetics.

[26]  Peter X.-K. Song,et al.  A Spatiotemporal Epidemiological Prediction Model to Inform County-Level COVID-19 Risk in the United States , 2020 .

[27]  M. Mina,et al.  To Interpret the SARS-CoV-2 Test, Consider the Cycle Threshold Value , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[28]  C. Gaydos Nucleic acid amplification tests for gonorrhea and chlamydia: practice and applications. , 2005, Infectious disease clinics of North America.

[29]  M. Yassour,et al.  Lessons from applied large-scale pooling of 133,816 SARS-CoV-2 RT-PCR tests , 2020, Science Translational Medicine.

[30]  A. Sterrett On the Detection of Defective Members of Large Populations , 1957 .

[31]  Joshua M Tebbs,et al.  Two‐Dimensional Informative Array Testing , 2012, Biometrics.

[32]  Joshua M Tebbs,et al.  Informative group testing for multiplex assays , 2019, Biometrics.